Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Di Marco

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
Lancet (London, England)|June 1, 1991
Second generation tests in diagnosis of chronic hepatitis CA Craxì, G Fiorentino, V Di Marco, et al.
The Journal of International Medical Research|January 1, 1985
Metabolic effects of buflomedil hydrochlorideF Briguglio, V Di Marco, C Circosta, et al.
Chirurgia E Patologia Sperimentale|April 1, 1970
[Influence of chronic hemodialysis on the hepatic chromosecretory capacity]M Zanghì, F Leone, O Ippolito, et al.
Diagnostic Microbiology and Infectious Disease|November 30, 2002
Corynebacterium macginleyi isolation from conjunctival swab in ItalyG M Giammanco, V Di Marco, I Priolo, et al.
Lancet (London, England)|October 31, 1992
Epilepsy, progressive cerebral calcifications, and coeliac diseaseA Fois, P Balestri, M Vascotto, et al.
Journal of Child Neurology|March 25, 1998
Segregation analysis in typical absence epilepsyS Buoni, S Grosso, G Di Cosmo, et al.
Hepatology (Baltimore, Md.)|April 1, 1994
Interferon-alpha for chronic hepatitis C: an analysis of pretreatment clinical predictors of responseL Pagliaro, A Craxí, C Cammaá, et al.
Epidemiology and Infection|June 16, 2015
Seroprevalence and risk factors of Toxoplasma gondii infection in humans in East Hararghe Zone, EthiopiaB Tilahun, Y Hailu, G Tilahun, et al.
Journal of Viral Hepatitis|June 23, 2011
TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1S Petta, V Di Marco, R Di Stefano, et al.
Alimentary Pharmacology & Therapeutics|December 29, 2016
Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver diseaseS Petta, S Ciminnisi, V Di Marco, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Lancet (London, England)|June 1, 1991
Second generation tests in diagnosis of chronic hepatitis CA Craxì, G Fiorentino, V Di Marco, et al.
The Journal of International Medical Research|January 1, 1985
Metabolic effects of buflomedil hydrochlorideF Briguglio, V Di Marco, C Circosta, et al.
Chirurgia E Patologia Sperimentale|April 1, 1970
[Influence of chronic hemodialysis on the hepatic chromosecretory capacity]M Zanghì, F Leone, O Ippolito, et al.
Diagnostic Microbiology and Infectious Disease|November 30, 2002
Corynebacterium macginleyi isolation from conjunctival swab in ItalyG M Giammanco, V Di Marco, I Priolo, et al.
Lancet (London, England)|October 31, 1992
Epilepsy, progressive cerebral calcifications, and coeliac diseaseA Fois, P Balestri, M Vascotto, et al.
Journal of Child Neurology|March 25, 1998
Segregation analysis in typical absence epilepsyS Buoni, S Grosso, G Di Cosmo, et al.
Hepatology (Baltimore, Md.)|April 1, 1994
Interferon-alpha for chronic hepatitis C: an analysis of pretreatment clinical predictors of responseL Pagliaro, A Craxí, C Cammaá, et al.
Epidemiology and Infection|June 16, 2015
Seroprevalence and risk factors of Toxoplasma gondii infection in humans in East Hararghe Zone, EthiopiaB Tilahun, Y Hailu, G Tilahun, et al.
Journal of Viral Hepatitis|June 23, 2011
TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1S Petta, V Di Marco, R Di Stefano, et al.
Alimentary Pharmacology & Therapeutics|December 29, 2016
Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver diseaseS Petta, S Ciminnisi, V Di Marco, et al.
Pageof 12